DEXCOM INC (DXCM)

US2521311074 - Common Stock

138.7  -0.78 (-0.56%)

After market: 138.54 -0.16 (-0.12%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
2.449B
27.08%
2.91B
18.84%
3.622B
24.49%
4.412B
21.80%
EBITDA
YoY % growth
395.9M
1.25%
561M
41.70%
800.3M
42.66%
1.238B
54.69%
EBIT
YoY % growth
293.9M
-9.26%
405.1M
37.84%
614.3M
51.64%
883.71M
43.86%
Operating Margin
12.00%13.92%16.96%20.03%
EPS
YoY % growth
0.67
-13.64%
0.87
30.83%
1.51
73.56%
1.78
18.01%
N/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
0.27
60.83%
Revenue
Q2Q % growth
928.12M
25.17%
EBITDA
Q2Q % growth
213.82M
EBIT
Q2Q % growth
128.51M
172.27%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth
0.50
47.06%
0.440.0613.60%
Q3 2023
Q2Q % growth
0.50
78.57%
0.350.1543.86%
Q2 2023
Q2Q % growth
0.34
100.00%
0.230.1147.36%
Q1 2023
Q2Q % growth
0.17
112.50%
0.150.0213.81%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth
1.035B
26.90%
1.036B-1.5M-0.14%
Q3 2023
Q2Q % growth
975M
26.69%
958.02M16.98M1.77%
Q2 2023
Q2Q % growth
871.3M
25.15%
858.45M12.85M1.50%
Q1 2023
Q2Q % growth
741.5M
17.92%
735.15M6.35M0.86%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0.24% -7.57% 1.61% 2.12%
Revenue-0.01% -0.97% -0.11% 0.18%